2011 - IPITA - Prague


Parallel session 4 – Open oral presentations Topic: Islet transplantation: Technical aspects

4.3 - Oxygen persufflation of the human pancreas increases ATP levels and improves viable islet yields compared with the two-layer method

Presenter: W.E., Scott III, Minneapolis, USA
Authors: W.E. Scott III, M.D. Rizzari, S.A. Stein, E.S. Avgoustiniatos, T.M. Suszynski, B.P. Weegman, L.A. Tempelman, B.E. Hammer, K.K. Papas



Oxygen persufflation of the human pancreas increases ATP levels and improves viable islet yields compared with the two-layer method

W.E. Scott III1, M.D. Rizzari1, S.A. Stein1, E.S. Avgoustiniatos1, T.M. Suszynski1, B.P. Weegman1, L.A. Tempelman2, B.E. Hammer3, K.K. Papas1
1 University of Minnesota, Department of Surgery, Minneapolis, MN, USA; 2 Giner, Inc., Newton, MA, USA; 3 University of Minnesota, Department of Radiology, Minneapolis, MN, USA

Objective: Many human pancreata arrive at isolation centers after 8-12 hr cold-ischemia time (CIT), resulting in reduced islet yields. We have shown in a porcine model that persufflation (PSF) is a promising alternative to current methods of preservation due to its ability to oxygenate tissue throughout preservation. The objective of this study was to investigate whether PSF can extend human pancreas preservation to 24 hr while maintaining islet yield and quality.

Methods: Human pancreata underwent PSF or were divided into paired segments during procurement and preserved by the two-layer method (TLM) or PSF. PSF was performed by providing 20 cc/min of 40%-humidified oxygen gas via the vasculature utilizing an electrochemical oxygen concentrator (Giner, Inc.). Using a 1.5T magnet, MRI was performed to determine PSF homogeneity and31P-NMR spectroscopy was performed to measure ATP-to-inorganic phosphate ratio (ATP:Pi), an indicator of organ viability during PSF, from 8-24 hr CIT. Following 8-12 hr TLM or 24 hr PSF, islets were isolated from paired segments and cultured for further assessment.

Results: All tested pancreata demonstrated homogeneous PSF visualized by negative contrast on MRI due to the presence of gas in the vasculature. In 7 pancreata exposed to continuous PSF, ATP:Pi levels measured from 8-24 hr CIT were maintained at 79±9% of the initial measurement. When PSF was stopped from 8-12 hr CIT, ATP fell to undetectable levels. Upon restoration of PSF, 44% of previous ATP:Pi was recovered. Initial paired islet isolation outcomes following 8-12 hr TLM or 24 hr PSF demonstrated higher viable islet yields and favorable morphology from PSF segments.

Conclusion: PSF is capable of maintaining ATP levels in human pancreata with modest decay over 24 hr CIT. Isolation results show that PSF may improve viable islet yields and extend the effective duration of preservation, supporting our previous findings in a porcine model.


Disclosure: A patent application has been filed on the use of an electrochemical oxygen concentrator for organ persufflation (WES, MDR, TMS, LAT, KKP).


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi